DAWNZERA
Live / Allowed — Notice of allowance issued (as of 14 Oct 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 19 Dec 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98913102
- Mark type
- Design + words
- Filed
- 19 Dec 2024
- Published for opposition
- 19 Aug 2025
- Attorney of record
- Brian Focarino
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of edema, namely hereditary angioedema; pharmaceutical preparations for the treatment of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders
Owner
- Ionis Pharmaceuticals, Inc., Carlsbad, CA, US
- Ionis Pharmaceuticals, Inc., Carlsbad, CA, US
Prosecution history
- 10 Mar 2026 — TEAS STATEMENT OF USE RECEIVED
- 10 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Feb 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Feb 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Dec 2025 — TEAS STATEMENT OF USE RECEIVED
- 14 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Aug 2025 — PUBLISHED FOR OPPOSITION
- 13 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE